Moderna Files FDA Application For The Lp.8.1 Targeting Covid-19 Vaccine

Moderna Inc MRNA:

• MODERNA FILES FDA APPLICATION FOR THE LP.8.1 TARGETING COVID-19 VACCINE

• MODERNA: SUBMISSION BASED ON GUIDANCE FROM U.S. FDA, WHICH ADVISED THAT COVID-19 VACCINES SHOULD BE UPDATED TO A MONOVALENT JN.1 LINEAGE - WEBSITE